Early PP Monitored by EIT in Patients With ARDS

Recruiting N/A Interventional Study
Acute Respiratory Distress Syndrome
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
60 (estimated)
Sponsor
Beijing Chao Yang Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Acute Respiratory Distress Syndrome (ARDS) is a syndrome characterized by respiratory distress and refractory hypoxemia caused by pulmonary and extra-pulmonary factors. Despite improvements in diagnosis and treatment in recent years, the mortality rate of severe ARDS is still around 40%. The distribution of lung lesions in ARDS patients is significantly gravity-dependent. Even with lung-protective…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Age ≥ 18 years old; 2. Meets the diagnostic criteria for ARDS according to the 2012 Berlin definition; 3. Intubation with invasive mechanical ventilation time \< 36 hours; 4. PaO2/FiO2 \< 150mmHg. Exclusion Criteria: 1. Contraindication to the prone position; 2. Contraindic…
Contacts

Yu Zhao, Dr.

+8618601342030

xuanben1985@163.com

CONTACT